Premier Alternatives

Checkerspot

Biotechnology · Alameda, CA · Founded 2016 · Privately Held (backing)

Developer of a biotechnology platform intended to engineer fats and oils through precision fermentation to create functional lipids that support nutritional needs across all life stages. Checkerspot is based in Alameda, CA and was founded in 2016. Its last reported valuation was $347 million in Sep 2022. It has raised $157 million across 5 recorded rounds; the latest was a $7.6 million early-stage round in Nov 2025.

Last reported valuation
$347.0M
Oct 2026
Priced at
—
Total raised
$157.0M
Last round
Early Stage VC
Nov 2025

Checkerspot key facts

as of Oct 2026
  • Developer of a biotechnology platform intended to engineer fats and oils through precision fermentation to create functional lipids that support nutritional needs across all life stages.
  • Checkerspot is valued at approximately $347.0M as of Oct 2026 (last reported valuation).
  • It has raised $157.0M across 5 recorded rounds; the latest was Early Stage VC ($7.6M) in Nov 2025.
  • Notable investors include Plug and Play Tech Center, Viking Global Investors, United States Department of Agriculture, Builders VC, Refactor Capital — 19 tracked in total.
  • Checkerspot has filed 4 Form Ds with the SEC since 2018, most recently Dec 2025 ($7.6M sold to 6 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$347.0M

Checkerspot's last reported valuation, Sep 2022. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Checkerspot with a free account
  • ·The complete investor list: 19 names
  • ·Watch Checkerspot: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Checkerspot funding rounds

5 rounds
Nov 2025Early Stage VC$7.6MSEC filing▮
Sep 2022Early Stage VC$40.0MSEC filing▮
Aug 2020Early Stage VC (Series B)$36.0M▮
Apr 2019Early Stage VC (Series A)$13.0M▮
May 2018Seed Round$5.4M▮
Full funding history →

Checkerspot valuation

Checkerspot's last reported valuation was $347 million in Sep 2022. No priced round, secondary trade or fund mark has surfaced since.

How much has Checkerspot raised?

Checkerspot has raised $157 million across 5 recorded rounds since 2018. The largest was a $7.6 million early-stage round in Nov 2025.

Checkerspot has filed 4 Form Ds with the SEC since 2018, most recently in Dec 2025 ($7.6 million sold to 6 investors).

Checkerspot investors

19 investors are on record for Checkerspot, including Plug and Play Tech Center, Viking Global Investors, United States Department of Agriculture and Builders VC. By type, the record holds 3 venture capital firms and 2 family offices. The early-stage round in Nov 2025 drew 6 investors.

Comparable companies

Comparable biotechnology names by valuation on PrivateMarketView: CellCentric ($382 million), Ansa Biotechnologies ($269 million) and Ambros Therapeutics ($250 million).

About Checkerspot

Developer of a biotechnology platform intended to engineer fats and oils through precision fermentation to create functional lipids that support nutritional needs across all life stages. The company's platform offers biology-driven lipid development and a molecule-licensing model, enabling food, nutrition, and ingredient partners to access sustainably produced functional lipids at scalable production levels and viable cost.

Industry
Biotechnology
Sector
Healthcare
HQ
Alameda, CA, United States
Founded
2016
Employees
34
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.